We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
The AGM was held between 6 and 8 October at Pompeu Fabra University, bringing together one hundred neuroblastoma experts.
Vall d'Hebron University Hospital organised the 2021 SIOPEN annual general meeting. The event was held between 6 and 8 October at Pompeu Fabra University in Barcelona, bringing together one hundred neuroblastoma experts. US and Australian experts also followed the AGM via live stream. SIOPEN is a European association that works to facilitate clinical, translational and basic research on neuroblastomas in children and adolescents, both in Europe and around the world. Dr Lucas Moreno, director of the Paediatric Oncology and Haematology Department at Vall d'Hebron University Hospital and principal investigator of the Translational Research in Childhood and Adolescent Cancer Research Group at the Vall d'Hebron Research Institute (VHIR), is the vice-president of the association.
“This AGM has been a great opportunity to make improvements to future and ongoing clinical trials and projects, to interact with clinicians and scientists from all across Europe, to collaborate with young researchers and to debate the future strategy of our association”, he explained. Vall d'Hebron, through the VHIR, is carrying out several studies on neuroblastomas and offers the hospital's paediatric patients who suffer from this pathology the opportunity to participate in clinical trials in all phases (1, 2 and 3). Vall d'Hebron University Hospital also has CSUR (Centre, Unit or Department of Reference) accreditation for this disorder. In other words, any paediatric patient in Spain who requires treatment for a neuroblastoma is accredited by the Ministry of Health to receive this treatment at Vall d’Hebron University Hospital.
Dr Moreno has spent his entire career trying to develop drugs for childhood cancer. His main area of research is neuroblastomas, which grow from nerve tissues and are one of the most aggressive forms of childhood cancer. They can be found in many parts of the body, but they are most commonly found in the abdomen, close to the spine or in the chest. Neuroblastomas can spread to the bones (face, skull, pelvis, shoulders, arms, legs) and into the bone marrow, liver, lymph nodes, skin and around the eyes.
Paediatric Oncology and Haematology, Children's Hospital and Woman's Hospital
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Vall d’Hebron University Hospital Foundation – Research Institute. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.